Heska Corp
HSKADelisted Jun 13, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001038133
Heska Corp was delisted on Jun 13, 2023; its insiders filed their last Form 4 on Jun 14, 2023; 152 institutions reported holding it in 13F filings for Q1 2023, worth $1.01B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Heska Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Heska Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Antin Robert L | Director | 0 | Jun 14, 2023 | 0 |
| Furlong Mark F | Director | 0 | Jun 14, 2023 | 0 |
| Larson Sharon J. | Director | 0 | Jun 14, 2023 | 0 |
| Davis Stephen L | Director | 0Indirect | Jun 14, 2023 | 0 |
| Wilson Kevin S. | CEO and President | 0Indirect | Jun 14, 2023 | 0 |
| Eyl Steven M. | EVP, CCO & Pres.scil | 0 | Jun 14, 2023 | 0 |
| Sveen David E. | Director | 0Indirect | Jun 14, 2023 | 0 |
| Humphrey Scott | Director | 0 | Jun 14, 2023 | 0 |
| Grassman Catherine | EVP, CFO | 0 | Jun 14, 2023 | 0 |
| Providenti Anthony C. Jr. | EVP, Corporate Development | 0 | Jun 14, 2023 | 0 |
| Baker Eleanor F. | EVP, Managing Dir. & COO, scil | 0 | Jun 14, 2023 | 0 |
| Sveen Christopher D. | CAO & General Counsel | 0 | Jun 14, 2023 | 0 |
| Hasenmaier Joachim A. | Director | 0 | Jun 14, 2023 | 0 |
| Wisnewski Nancy | Chief Operating Officer | 81,083 | Sep 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 (view filing) | Jan 6 | 3 days | Wilson Kevin S.CEO and President | PPurchase | +11.0K | $58.62 | +$645.9K | +7.1%167.1K after | 2 lots |
| Dec 27, 2022 (view filing) | Dec 22 | 5 days | Wilson Kevin S.CEO and President | PPurchase | +3.44K | $59.64 | +$205.2K | +2.3%156.1K after | 4 lots |
| Mar 3, 2022 (view filing) | Mar 3 | Same day | Baker Eleanor F.EVP, Managing Dir. & COO, scil | SSale | −663 | $146.34 | −$97.0K | −16.3%3.40K after | 8 lots |
| Nov 23, 2021 (view filing) | Nov 23 | Same day | Wilson Kevin S.CEO and President | PPurchase | +1.00K | $173.00 | +$173.0K | +12.5%9.00K after | |
| Nov 15, 2021 (view filing) | Nov 15 | Same day | Wilson Kevin S.CEO and President | PPurchase | +1.00K | $179.00 | +$179.0K | +14.3%8.00K after | |
| Aug 19, 2021 (view filing) | Aug 18 | 1 day | Wisnewski NancyChief Operating Officer | SSale | −1.00K | $270.33 | −$270.3K | −1.8%54.5K after | 12 lots |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Larson Sharon J.Director | SSale | −2.00K | $266.83 | −$533.7K | −21.1%7.50K after | |
| Aug 9, 2021 (view filing) | Aug 6 | 3 days | Grassman CatherineEVP, CFO | SSale | −5.00K | $260.24 | −$1.30M | −55.6%3.99K after | 3 lots |